-
by
Kristin Palpini
Breaking News
An estimated timeline for when children and teens will be able to get COVID-19 vaccinated was recently laid out by Dr. Anthony Fauci.Some of the youngest children won’t be vaccinated until 2022.On Sunday, Feb. 28, Fauci, head of the National Institute of Allergy and Infectious Diseases, said that high school students could begin receiving the vaccine in the fall. Younger children, he ...
-
by
Zak Failla
Breaking News
Tens of thousands of the Johnson & Johnson COVID-19 vaccine have been earmarked for Connecticut, provided it gains federal approval for emergency use by an oversight committee, possibly as soon as this weekend.This week, the Food and Drug administration staff endorsed the new vaccine, which would only require one dose and is easier to store than the current Pfizer and Moderna ...
-
by
Zak Failla
Breaking News
The Food and Drug Administration's staff has endorsed Johnson & Johnson’s COVID-19 vaccine for emergency use, paving the way for the one-dose shot to receive its final approval for emergency use in America by a final committee.This week, the FDA announced it supported the approval of the vaccine, which is easier to store and would represent a third vaccination option for those ...
-
by
Kristin Palpini
Breaking News
The U.S. doesn’t have enough of the COVID-19 vaccine to innoculate everybody right now and likely won’t have the appropriate supplies for months to come, said Dr. Anthony Fauci.This announcement signals a pushed-back timeframe for when the COVID-19 vaccine will be readily available to the public. Widespread availability is now expected in May or June, he said. Originally, Fauci had ...
-
by
Zak Failla
Breaking News
Some relief may be on the way for the millions of people awaiting their turn to receive the COVID-19 vaccine.Johnson & Johnson has been developing a single-dose vaccine for COVID-19, which has an efficacy rate of approximately 72 percent, potentially bringing another provider into the mix as vaccines for the virus have become a valuable and scarce commodity.If it is ultimately ...
-
by
Onisis Stefas, PharmD, Northwell Health, Phelps Hospital
Your Community
The COVID vaccines being rolled out do not use inactive virus to build immunity, rather messenger RNA (mRNA) technology as a novel way of preventing illnessSandra Lindsay’s bravery and wisdom spoke volumes when she became the first person in the US to receive the COVID-19 vaccine. “Healing is coming,” she said directly after getting the shot, iconic yet profound words that will ...
-
by
Onisis Stefas, PharmD, Northwell Health, Phelps Hospital
Your Community
The COVID vaccines being rolled out do not use inactive virus to build immunity, rather messenger RNA (mRNA) technology as a novel way of preventing illnessSandra Lindsay’s bravery and wisdom spoke volumes when she became the first person in the US to receive the COVID-19 vaccine. “Healing is coming,” she said directly after getting the shot, iconic yet profound words that will ...
-
by
Jerry DeMarco
Breaking News
More reliable than the flu shot? Pfizer on Monday trumpeted a COVID-19 vaccine candidate as more than 90% effective – nearly three times better than the effectiveness of last season’s influenza vaccine.Pfizer said it hopes to have 50 million doses of the free vaccine ready by the end of this year and as many as 1.3 billion doses available next year to fight the deadly global ...
-
by
Jerry DeMarco
Breaking News
A mystery illness suffered by a participant has put the largest COVID-19 vaccine trial on hold, drug maker Johnson & Johnson announced.The New Jersey-based company – which sought 60,000 volunteers mostly over 60 – didn’t describe the illness or identify the patient in any way.“We must respect this participant's privacy,” J&J said in a statement. “We're also learning more about ...
-
by
Cecilia Levine
Breaking News
New Jersey-based Johnson & Johnson has paused its COVID-19 vaccine study because of an unexplained illness among a participant.Researchers running the 60,000 patient trial received a notice saying the "pausing rule has been met," Stat News reports.The online patient-enrolling system was subsequently closed and a meeting for the patient safety monitoring board comprised of ...
-
by
Jerry DeMarco
Breaking News
Jurors in New Brunswick on Thursday rendered a $750 million punitive damages verdict against Johnson & Johnson on behalf of four people who allegedly got mesothelioma from its baby powder – and a judge immediately cut the award to $185 million, NJ.LAW reported.Johnson & Johnson vowed to appeal.The jury deliberated for less than a day following a three-week trial, the site ...
-
by
Zak Failla
Breaking News
Johnson & Johnson announced a voluntary recall of 33,000 bottles due to low levels of potential asbestos contamination.The recall, which is limited to lot #22318RB, were produced and shipped nationwide last year. It comes after the US Food and Drug Administration test that found levels of chrysotile asbestos contamination in samples from a bottle purchased online, according to the ...